Plaintiffs, appealing three defense verdicts, responded on Friday to a cross-appeal that sought to toss 20,000 cases over Xarelto on federal pre-emption.
January 28, 2019 at 04:58 PM
1 minute read
The original version of this story was published on Almstaff
Plaintiffs appealing defense verdicts in the first bellwether trials over the blood thinner Xarelto are fighting back against an attempt by the drug manufacturers to toss out all 20,000 cases in federal court on federal pre-emption grounds.
Presented by BigVoodoo
Law firms & in-house legal departments with a presence in the middle east celebrate outstanding achievement within the profession.
The premier educational and networking event for employee benefits brokers and agents.
The Legal Intelligencer honors lawyers leaving a mark on the legal community in Pennsylvania and Delaware.
A large and well-established Tampa company is seeking a contracts administrator to support the company's in-house attorney and manage a wide...
We are seeking an attorney to join our commercial finance practice in either our Stamford, Hartford or New Haven offices. Candidates should ...
We are seeking an attorney to join our corporate and transactional practice. Candidates should have a minimum of 8 years of general corporat...
MELICK & PORTER, LLP PROMOTES CONNECTICUT PARTNERS HOLLY ROGERS, STEVEN BANKS, and ALEXANDER AHRENS
